IntoCell financial statements

인투셀KRX:287840 · KOSDAQ
₩18,260-0.33%
2026-10-07 close

IntoCell's 2025 annual results accompany close-price data dated 2026-10-07. 2025 revenue was KRW 2.3B. 2025 operating profit was −KRW 10.3B.

Reported results

IntoCell notifications

Quantus Signal · live data · not investment advice · Privacy Policy